KANTARO BIOSCIENCES
DEAD

Serial Number

88922068

Owner

Kantaro Biosciences LLC

Attorney

Michelle A. Cooke

Filing Date

May 18, 2020

Add to watchlist:

No watchlists yet
View on USPTO

KANTARO BIOSCIENCES Trademark

Serial Number: 88922068

KANTARO BIOSCIENCES is a trademark filed by Kantaro Biosciences LLC on May 18, 2020. The trademark is classified under Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Kantaro Biosciences LLC (13 trademarks)

1460 Broadway
New York, NY 10036

Entity Type: 16

Trademark Details

Filing Date

May 18, 2020

Registration Date

Not Registered

Goods & Services

Medical, pharmaceutical, scientific and clinical research and analysis; Medical and scientific research in the fields of viral and infectious diseases; Design and development of medical diagnostic test kits; Research, analysis, design, development and consultancy services relating to apparatus, instruments, devices and equipment for medical diagnostics and testing, medical diagnostic tests, medical devices, pharmaceutical preparations and treatments, vaccines and medicines; Providing medical testing services and information in the field of medical and viral and infectious diseases research; Development of scientific research and technology for purposes of disease testing, diagnosis, testing, monitoring, prevention, treatment, rehabilitation and health maintenance; Conducting clinical trials of medical and pharmaceutical products; Research and development of pharmaceuticals for the treatment of infections, viruses, and infectious, viral, communicable, blood borne pathogen, vector borne, pulmonary, respiratory, inflammatory, immunological, autoimmune, rheumatic and cardiovascular diseases and disorders; Providing a website featuring information about medical devices, diagnostics, research, analysis, monitoring and treatment of infections, viruses and infectious, viral, communicable, blood borne pathogen, vector borne, pulmonary, respiratory, inflammatory, immunological, autoimmune, rheumatic and cardiovascular diseases and disorders; Research regarding development of vaccines and medicines

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Mar 16, 2021 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Mar 16, 2021 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 1, 2020 GNRN
NON-FINAL ACTION E-MAILED
Sep 1, 2020 GNRT
NON-FINAL ACTION WRITTEN
Sep 1, 2020 CNRT
ASSIGNED TO EXAMINER
Aug 15, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 3, 2020 NWOS
NEW APPLICATION ENTERED
May 21, 2020 NWAP